- Biologics by McKesson’s Pharmacy Elite was selected as Rigel’s hub for Tavalisse, Gavreto, and Rezlidhia, supporting access services including benefits investigation, prior authorization, and financial assistance navigation.
- Biologics by McKesson became the sole specialty pharmacy provider for AQVESME, indicated for adults with non-transfusion-dependent or transfusion-dependent alpha- or beta-thalassemia.
- Learn how McKesson connects biopharma, providers and patients to deliver precision oncology at scale through integrated logistics, specialty pharmacy and high‑touch support.
- Biologics by McKesson was selected as a limited specialty pharmacy provider for Komzifti, an oral menin inhibitor for adults with relapsed or refractory NPM1-mutated acute myeloid leukemia.
- Biologics by McKesson was selected as a limited specialty pharmacy provider for Inluriyo, an oral estrogen receptor antagonist for ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer.
- Biologics by McKesson was selected as a limited specialty pharmacy provider for PALSONIFY, the first once-daily oral therapy for adults with acromegaly who need an alternative to surgery.